<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Matsumoto, Alvin</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Meeting the Challenges of Diagnosing and Managing Male Hypogonadism</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-25</style></pages><abstract><style  face="normal" font="default" size="100%">Male hypogonadism raises many questions about who should be treated and what the treatment should be. The Endocrine Society published updated guidelines on testosterone therapy for androgen deficiency syndromes in adult men in 2010 [Bhasin S et al. JCEM 2010].</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>